CCIDA sponsors industry to participate in AW2026 Shanghai Fashion Week
Sponsored by the Cultural and Creative Industries Development Agency (CCIDA) under the Culture, Sports and Tourism Bureau and organised by the Hong Kong Design Centre (HKDC), the "Asian Designers To Watch x Hong Kong Emerging Designers" at the AW2026 Shanghai Fashion Week (SHFW) concluded yesterday (March 30).
Highlights of the "Asian Designers To Watch x Hong Kong Emerging Designers" included a designer exhibition and a fashion show. The exhibition, held from March 25 to 30, featured 21 selected fashion pieces by seven Asian Designers To Watch of the 2025 edition and over 160 AW2026 fashion and accessory pieces by 10 Hong Kong emerging designers. The fashion show, held on March 27 as the HKDC's debut at the SHFW, showcased 40 selected AW2026 outfits by five emerging Hong Kong designers and brands, presenting to Chinese Mainland and international audiences the vitality of Hong Kong fashion. The two highlight events provided a platform for Hong Kong designers to network with buyers from around the world during the SHFW, one of the most influential fashion events in Asia, and explore potential business opportunities.
The HKDC is CCIDA's strategic partner in leveraging Hong Kong's East-meets-West advantage to drive economic value from design. CCIDA has been supporting the HKDC's initiatives for exploring markets for local design talent and enterprises, including organising industry delegations to participate in major design and fashion events on the Chinese Mainland and overseas, to enhance the global visibility of Hong Kong's design industry and foster cross-boundary collaborations.
For more information on event, please visit www.hkdesigncentre.org and www.fashionasiahk.com.
Sponsored by the Cultural and Creative Industries Development Agency and organised by the Hong Kong Design Centre, the "Asian Designers To Watch x Hong Kong Emerging Designers" at the AW2026 Shanghai Fashion Week concluded yesterday (March 30). Photo shows industry representatives from around the world attending and networking at the "Asian Designers To Watch x Hong Kong Emerging Designers". Source: HKSAR Government Press Releases
Sponsored by the Cultural and Creative Industries Development Agency and organised by the Hong Kong Design Centre, the "Asian Designers To Watch x Hong Kong Emerging Designers" at the AW2026 Shanghai Fashion Week concluded yesterday (March 30). Photo shows selected AW2026 outfits by emerging Hong Kong designers and brands at the "Asian Designers To Watch x Hong Kong Emerging Designers" fashion show. Source: HKSAR Government Press Releases
Sponsored by the Cultural and Creative Industries Development Agency and organised by the Hong Kong Design Centre, the "Asian Designers To Watch x Hong Kong Emerging Designers" at the AW2026 Shanghai Fashion Week concluded yesterday (March 30). Photo shows some of the pieces at the designer exhibition of the "Asian Designers To Watch x Hong Kong Emerging Designers". Source: HKSAR Government Press Releases
DH follows up on medical incident reported by Tuen Mun Hospital
In response to Tuen Mun Hospital (TMH)'s announcement of a sentinel event, the Department of Health (DH) today (May 15) said that the DH is investigating the incident and following up with the local responsible person (LRP) of the medical device concerned.
On May 13, the DH received a notification from the Hospital Authority (HA) indicating that air bubbles had been detected in the coronary artery of a 75-year-old male patient during a Percutaneous Coronary Intervention (PCI) performed earlier at TMH. According to the preliminary information provided by the HA, it is suspected that the incident is related to the pressure monitoring set used during the procedure.
As the pressure monitoring set in question is listed under the DH's Medical Device Administrative Control System (MDACS), upon receiving the notification, the DH immediately took the following follow-up actions:
Contacted the LRP of the medical device concerned to ascertain the details and requested the LRP to conduct an investigation and submit an investigation report;
As a precautionary measure, the LRP has been instructed to immediately suspend sales of the affected batch and to contact all users in Hong Kong who are using medical devices from the same batch to advise them to temporarily stop using the affected product. To date, the DH has not received any adverse event reporting regarding this medical device from other users; and
Issued a Special Alert on the DH's Medical Device Division website and notified stakeholders, urging users who possess the affected product to temporarily suspend their use and contact the LRP for follow up.
DH's investigation is ongoing. The DH will continue to maintain close communication with the LRP, closely monitor the situation and take follow-up actions based on the investigation report.
The DH introduced the voluntary Medical Device Administrative Control System (MDACS) in 2004, under which a listing system for medical devices and traders as well as a post-market monitoring system for the products are put in place. All listed medical devices meet the safety, quality and performance requirements. Currently, over 9 000 medical devices are listed under the MDACS. Over the past three years, the DH has not received any safety alerts or adverse event reports involving the pressure monitoring set concerned. In response to the latest international regulatory trends, the Government is formulating the statutory regulatory requirements and will consult various stakeholders as appropriate within this year before submitting the legislative proposal to the Legislative Council. The implementation of a statutory registration system for medical devices aligns with the policy directions set out by the Chief Executive in the 2023, 2024 and 2025 Policy Addresses to accelerate the implementation of reforms to the evaluation, approval and registration mechanism for medical products. The HKSAR Government plans to introduce a bill in the second half of this year to achieve the goal of establishing the Hong Kong Centre for Medical Products Regulation (CMPR) under the DH by the end of 2026. Upon its establishment, the CMPR will systematically consolidate the regulatory functions for Western and Chinese medicines as well as medical devices. By leveraging existing legislation governing Western and Chinese medicines and the proposed statutory regulatory framework for medical devices, the CMPR will comprehensively enhance the regulatory and approval mechanism for medical products, thereby supporting Hong Kong's development as an international Health and Medical Innovation Hub.
Source: AI-found images
